Latest Articles
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - riauone.com
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 riauone.com
Published: June 15, 2026, 12:29 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - The Manila Times
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 The Manila Times
Published: June 14, 2026, 10:21 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - NTB Kommunikasjon
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 NTB Kommunikasjon
Published: June 14, 2026, 10:05 p.m.
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer - dailynews.lk
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer dailynews.lk
Published: June 14, 2026, 7:42 p.m.
International Experts Convene in Tenerife to Discuss Advances in Gynaecological Cancer - Tenerife Weekly News
International Experts Convene in Tenerife to Discuss Advances in Gynaecological Cancer Tenerife Weekly News
Published: April 23, 2026, 10:33 a.m.
Step Pharma Secures €2.5 Million EIC Grant To Advance Dencatistat In CTPS2 Null Gynaecological Cancers - Pulse 2.0
Step Pharma Secures €2.5 Million EIC Grant To Advance Dencatistat In CTPS2 Null Gynaecological Cancers Pulse 2.0
Published: Feb. 22, 2026, 1:56 p.m.
Women with metabolic syndrome face higher risk of gynaecological cancers, finds study - The Hindu
Women with metabolic syndrome face higher risk of gynaecological cancers, finds study The Hindu
Published: Oct. 16, 2025, 4:18 p.m.
Women come together to empower and raise awareness of gynaecological cancers - Dairy News Australia
Women come together to empower and raise awareness of gynaecological cancers Dairy News Australia
Published: Oct. 1, 2025, 5:14 a.m.
GSK enters Indian oncology market with gynaecological cancer drugs - MSN
GSK enters Indian oncology market with gynaecological cancer drugs MSN
Published: Aug. 28, 2025, 8:16 a.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - India Education Diary
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers India Education Diary
Published: Aug. 25, 2025, 3:28 p.m.
Link copied to clipboard!